Retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8530517
APP PUB NO 20110312965A1
SERIAL NO

13141831

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to new retinoid derivatives of formula I and to pharmaceutical compositions containing them for the treatment of patients affected by pathologies such as arthritic conditions, tumors, metastatic cancer, diabetic retinopathy, psoriasis, chronic inflammatory diseases or atherosclerosis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S P AITALY ROME ROMA ROME

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Alloatti, Domenico Rome, IT 8 16
Battistuzzi, Gianfranco Rome, IT 4 8
Brunetti, Tiziana Pomezia, IT 3 0
Cabri, Walter Rozzano, IT 98 224
Dallavalle, Sabrina Vimercate, IT 14 26
Giannini, Giuseppe Pomezia, IT 46 223
Pisano, Claudio Aprilia, IT 60 146

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 10, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00